Marantz A - Search Results

1

Prognosis of metastatic giant cell tumor of bone in the pre-denosumab era. A systematic review and a meta-analysis.

Itkin B, Straminsky S, De Ronato G, Lewi D, Marantz A, Bardach A. Itkin B, et al. Among authors: marantz a. Jpn J Clin Oncol. 2018 Jul 1;48(7):640-652. doi: 10.1093/jjco/hyy067. Jpn J Clin Oncol. 2018. PMID: 29741702 Review.

2

Neoadjuvant chemotherapy with cisplatin, ifosfamide and 5-fluorouracil in the treatment of locally advanced cervical cancer.

Etcheverry MG, Marantz A, Saine M, Litovska S, Lewi D, Cecchin G, De Pierro AN. Etcheverry MG, et al. Among authors: marantz a. Int J Gynecol Cancer. 2000 Jan;10(1):53-58. doi: 10.1046/j.1525-1438.2000.99077.x. Int J Gynecol Cancer. 2000. PMID: 11240651

3

Phase II study of gemcitabine, 5-fluorouracil, and leucovorin in patients with pancreatic cancer.

Marantz A, Jovtis S, Almira E, Balbiani L, Castilla JL, Fein L, Lewi D, Pasccon G, Pinckevicius R, Uranga G, Abal M, Muiño M, Reale M, Agusto S; Grupo de Tumores Gastrointestinales. Marantz A, et al. Semin Oncol. 2001 Jun;28(3 Suppl 10):44-9. doi: 10.1053/sonc.2001.23807. Semin Oncol. 2001. PMID: 11510033 Clinical Trial.

4

[The dilemma of cancer therapy and the oncologist-patient relationship].

Litovska S, Navigante A, Marantz A. Litovska S, et al. Among authors: marantz a. Medicina (B Aires). 1998;58(5 Pt 1):531-2. Medicina (B Aires). 1998. PMID: 9922492 Spanish. No abstract available.

5

The cyclophosphamide, hexamethylmelamine, 5 fluorouracil (CHF) regimen in the treatment of advanced and recurrent ovarian cancer.

Posada JG Jr, Marantz AB, Yeung KY, Smith FP, Delgado G, Edwards BK, Schein PS. Posada JG Jr, et al. Among authors: marantz ab. Gynecol Oncol. 1985 Jan;20(1):23-31. doi: 10.1016/0090-8258(85)90121-0. Gynecol Oncol. 1985. PMID: 3917421

6

Prevention of adriamycin-induced cardiotoxicity by prenylamine: a pilot double blind study.

Milei J, Marantz A, Alé J, Vazquez A, Buceta JE. Milei J, et al. Among authors: marantz a. Cancer Drug Deliv. 1987;4(2):129-36. doi: 10.1089/cdd.1987.4.129. Cancer Drug Deliv. 1987. PMID: 3427552 Clinical Trial.

7

A controlled trial of the effect of 4-hydroxypyrazolopyrimidine (allopurinol) on the toxicity of a single bolus dose of 5-fluorouracil.

Woolley PV, Ayoob MJ, Smith FP, Lokey JL, DeGreen P, Marantz A, Schein PS. Woolley PV, et al. Among authors: marantz a. J Clin Oncol. 1985 Jan;3(1):103-9. doi: 10.1200/JCO.1985.3.1.103. J Clin Oncol. 1985. PMID: 3965628

8

FAM (5-fluorouracil, doxorubicin, and mitomycin) plus triazinate (FAM-T) in gastric carcinoma: a combined phase II trial of the Mid-Atlantic Oncology Program and the Pan American Health Organization.

Ahlgren JD, Smith FP, Cazap E, Estevez RA, Marantz A, Woolley PV, Wilcosky T, Stein J, Schein PS. Ahlgren JD, et al. Among authors: marantz a. Cancer Treat Rep. 1987 Apr;71(4):419-20. Cancer Treat Rep. 1987. PMID: 3548959 Clinical Trial. No abstract available.

9

Prenylamine inhibition of adriamycin-induced cardiomyopathy in mice.

Milei J, Bolomo NJ, Marantz A. Milei J, et al. Among authors: marantz a. Medicina (B Aires). 1982;42(4):409-14. Medicina (B Aires). 1982. PMID: 15171023 No abstract available.

10

Sequential methotrexate, 5-fluorouracil (high-dose), and doxorubicin for advanced gastric cancer.

Muro H, Acuña LR, Castagnari A, Blajman C, Schmilovich A, Hidalgo A, Fiori H, Bader M, Marantz A. Muro H, et al. Among authors: marantz a. Cancer Treat Rep. 1986 Nov;70(11):1333-4. Cancer Treat Rep. 1986. PMID: 3768875 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

63 results

Search Page

Filters